| Etiology of glomerulonephritis | n (%) | Concomitantly used medications that may change tacrolimus serum level | n (%) |
| Minimal change disease (MCD) | 32 (22.1) | Rosuvastatin (ROSU) | 36 (24.8) |
| Membranous nephropathy (MN) | 11 (7.6) | Steroids (STER) | 47 (32.4) |
| Focal segmental glomerulosclerosis (FSGS) | 12 (8.3) | Omeprazole (OMEP) | 4 (2.7) |
| IgA nephropathy | 40 (27.6) | Nifedipine (NIFE) | 3 (2.0) |
| Membrano-proliferative glomerulonephritis (MPGN) | 6 (4.1) | Rifampin (RIFA) | 1 (0.6) |
| Lupus nephritis | 19 (13.1) | ||
| Glomerulonephritis (GN) | 5 (3.4) | ||
| Henoch-Schönlein purpura nephritis (HSP) | 5 (3.4) | ||
| Other glomerulonephritis | 15 (10.3) |